✦ LIBER ✦

Late lines of treatment benefit survival in metastatic breast cancer in current practice?

✍ Scribed by E. Planchat; C. Abrial; E. Thivat; M.A. Mouret-Reynier; F. Kwiatkowski; C. Pomel; Q. Wang-Lopez; P. Chollet; J.M. Nabholtz; X. Durando

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Loco-regional treatment in metastatic br

✍ Bevan H. Ly; Nam P. Nguyen; Vincent Vinh-Hung; Elisabetta Rapiti; Georges Vlasto 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 237 KB

Bevacizumab in First-Line Treatment of M

✍ David Miles 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 46 KB

Bevacizumab in First-Line Treatment of M

✍ Xavier Pivot 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 45 KB

Cetuximab adds benefit in first-line tre

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Bevacizumab in the first-line treatment

✍ David Cameron 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 386 KB

Epirubicin + docetaxel in first-line tre

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 138 KB